Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-26 @ 1:43 AM
Study NCT ID:
NCT00075933
Status:
COMPLETED
Last Update Posted:
2009-04-28
First Post:
2004-01-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
ARQ 501 in Subjects With Cancer
Sponsor:
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2007-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-01
Completion Date Type:
ACTUAL
First Submit Date:
2004-01-12
First Submit QC Date:
None
Study First Post Date:
2004-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-04-27
Last Update Post Date:
2009-04-28
Last Update Post Date Type:
ESTIMATED